An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) will be hosting a conference call on May 7, 2024, to discuss its first quarter 2024 financial results. The call will take place at 8:30 a.m. ET, with options to access via phone or webcast. A replay will be available for 90 days post-event.
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) terrà una conferenza telefonica il 7 maggio 2024 per discutere i risultati finanziari del primo trimestre del 2024. La chiamata si svolgerà alle 8:30 a.m. ET, con opzioni di accesso tramite telefono o webcast. Una registrazione dell'evento sarà disponibile per 90 giorni successivi.
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) organizará una llamada de conferencia el 7 de mayo de 2024 para discutir sus resultados financieros del primer trimestre de 2024. La llamada tendrá lugar a las 8:30 a.m. ET, con opciones para acceder por teléfono o webcast. Se dispondrá de una repetición disponible durante 90 días posteriores al evento.
Apellis Pharmaceuticals, Inc. (나스닥: APLS)는 2024년 5월 7일에 2024년도 1분기 재무 결과에 대해 논의하기 위한 전화 회의를 주최할 예정입니다. 전화 회의는 동부 표준시 오전 8시 30분에 진행되며, 전화 또는 웹캐스트를 통해 접근할 수 있는 옵션이 제공됩니다. 행사 후 90일 동안 재생이 가능합니다.
Apellis Pharmaceuticals, Inc. (Nasdaq : APLS) organisera une conférence téléphonique le 7 mai 2024 pour discuter de ses résultats financiers du premier trimestre 2024. L'appel aura lieu à 8h30 ET, avec des options d'accès par téléphone ou webcast. Un enregistrement sera disponible pendant 90 jours après l'événement.
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) wird am 7. Mai 2024 einen Conference Call abhalten, um die Finanzergebnisse des ersten Quartals 2024 zu besprechen. Der Anruf findet um 8:30 Uhr ET statt und ist per Telefon oder Webcast zugänglich. Eine Aufzeichnung wird 90 Tage nach dem Ereignis verfügbar sein.
Positive
None.
Negative
None.
WALTHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2024 financial results on Tuesday, May 7, 2024, at 8:30 a.m. ET.
To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 90 days following the event.
About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
When will Apellis Pharmaceuticals host a conference call to discuss its first quarter 2024 financial results?
Apellis Pharmaceuticals will host the conference call on May 7, 2024.
What is the ticker symbol for Apellis Pharmaceuticals?
The ticker symbol for Apellis Pharmaceuticals is APLS.
How can I access the conference call by phone?
To access the conference call by phone, pre-register for the call on the company's website.
Where can I find the live audio webcast and accompanying slides of the event?
The live audio webcast and slides can be accessed through the 'Events and Presentations' page of the 'Investors and Media' section of the company's website.
How long will the replay of the webcast be available?
The replay of the webcast will be available for 90 days following the event.
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
